The Deloitte Touche Tohmatsu (DTT) Life Sciences and Healthcare (LSHC) industry group with LSHC specialists from DTT member firms, is comprised of more than 5,400 professionals in over 47 countries. Their understanding of the industry’s challenges and their ability to quickly respond with integrated, comprehensive services put the DTT member firms in a unique position to help their clients. These professionals can help companies in their efforts to bring discoveries to life and to improve the quality of care while they create and sustain long-term, bottom-line profitability.
The Luxembourg firm has a team of professionals with broad industry expertise working in various fields within the life sciences and healthcare industry. It has recently been strengthened with additional life sciences and healthcare projects, in particular through projects in organisational, human capital and IT areas, for clients such as:
DTT member firms provide professional services to:
Since January 2006 Deloitte & Touche GmbH Wirtschaftsprüfungsgesellschaft is the unique shareholder of Gebera - Gesellschaft für betriebswirtschaftliche Beratung mbH. For over 30 years Gebera has provided answers to challenges in the healthcare sector and the company has an extensive expertise in the hospital sector.
In July 2008, Recombinant Capital, Inc. was purchased by Deloitte LLP and is now known as Deloitte Recap LLC (Recap). Recap offers biopharmaceutical business intelligence subscription tools and consulting services tailored toward business development, corporate strategy, financial, legal, academic and R&D professionals. Recap recently launched a new series of biopharmaceutical business intelligence tools, the Recap IQ Series by Deloitte™, providing analytical tools to help life sciences companies leverage comprehensive biopharma alliance data, deal values and drug development histories to support the development of alliance and clinical development strategies.
In August 2011, Intrasphere, a leading consulting business in the areas of drug safety, signal intelligence, pharmacovigilance and regulatory information management, joined Deloitte. PharmaCM®, Intrasphere’s renowned content management platform for life sciences organisations which enables the clinical trial information registration process, is now available to Deloitte and their clients.
|An ongoing collaboration has been established with the Economist Intelligence Unit (EIU) for surveying life sciences executives on the future of the life sciences industry.|
|A long-standing relationship is sustained with the forum’s healthcare governors group to analyse topics such as emerging markets issues and innovations in the area of healthcare.|
|Deloitte is a long-standing member of the Biotechnology Industry Organization. Deloitte professionals participate as moderators and panellists at the annual BIO Convention, an event which is attended by more than 20,000 industry executives.|
|Deloitte is a prominent sponsor of the BioPartnering Europe, an event that provides partnering and networking opportunities for decision-makers from leading biotechnology, pharmaceutical and investment companies from around the world through one-to-one partnering meetings, presentations, expert panels and exhibitions.|
|Forbes Insights is a new program for FY10 that will develop three spot surveys of current ‘top of mind’ industry topics related to life sciences and health care.|
|The Financial Times — Deloitte is the lead sponsor of FT’s Pharmaceutical and Biotechnology Conference, one of Europe's pre-eminent industry events attended by leading executives, government decision-makers, investors, analysts and other specialist providers.|
|Health Information and Management Systems Society (HIMSS) — Deloitte is an active member of this leading industry organisation for the healthcare information technology sector.|